Supporting Foot/Ankle Surgeon Inventors

Nextremity Solutions Inc., a musculoskeletal product development company located in “The Orthopedic Capital of the World” Warsaw, Ind., recently finalized an exclusive global distribution agreement with Zimmer Biomet for its first four commercialized products, which address unmet clinical needs in forefoot elective surgery.
 
“Bringing this agreement to closure validates the strategy that our executive management team put into motion at the beginning of the year with the support of our Board of Directors. This strategic shift in our business strategy enables us to focus our efforts on product development and micro-commercialization of innovative technologies in musculoskeletal healthcare,” stated Rod K. Mayer, president and CEO of Nextremity Solutions Inc.
 
i3 Strategic Solutions is Nextremity Solutions’ new strategy to deliver value for Nextremity shareholders and for their industry partners. Through the i3 Strategic Solutions strategy, Nextremity will continue to work with surgeons who are thought leaders in their respective fields to develop and commercialize innovative solutions—at present to the foot and ankle market. In addition to delivering innovative products, Nextremity Solutions is committed to establishing effective packaging and delivery systems, creating effective marketing and educational support materials, and providing products with proven sales and clinical efficacy to their industry partners.
 
“Nextremity Solutions, Inc. has learned a lot over the last four years, and we’re taking the best of what we do and doing more of it, more profitably, every day. We’re passionate about serving surgeons, patients, and our industry partners. This has led us to the introduction of i3 Strategic Solutions and we couldn’t be more excited about our future,” stated Ryan D. Schlotterback, executive director, product development for Nextremity Solutions Inc.
 
“It’s what we call our ‘micro-commercialization’ model and is what makes our solutions very different—and more effective,” commented Schlotterback.
 
Schlotterback further stated, “i3 Strategic Solutions embodies our vision for Nextremity Solutions and is the right model for our future. We are committed to our micro-commercialization strategy and believe that we have the opportunity to deliver solutions to the market in a way that truly leverages our strengths and the strengths of our industry partners, while creating the greatest level of value for everyone involved. We have a very strong internal pipeline and have several external opportunities that we’ve been presented with over the last six months that we plan to support with our new model.”